Mercury Pharmaceuticals

Researchers trace soaring poison control calls to semaglutide approval for weight loss

When semaglutide's popularity exploded following FDA approval for weight management in 2021, so too did a wave of calls to poison control centers.

Scientists discover how food poisoning bacteria protect themselves from antibiotics

Scientists from the Department of Microbiology of the University of Malaga, also members of the Institute of Subtropical and Mediterranean Horticulture 'La Mayora' (IHSM), have discovered a hitherto unknown mechanism that allows the bacterium Bacillus cereus, which is responsible for food poisoning and human infections, to protect itself against antibiotics and adverse conditions.

UCI Health launches world's first embryonic stem cell trial for Huntington's disease

UCI Health, the clinical enterprise of the University of California, Irvine, has opened the world's first in-human embryonic stem cell-derived clinical trial for Huntington's disease.

NIH funding supports development of AI tools to prevent HIV, hepatitis C and overdose

Natasha Martin, DPhil, professor and vice chief of Global Public Health in the Division of Infectious Diseases and Global Public Health at UC San Diego School of Medicine, has been awarded a five-year, $5.6 million Avant-Garde Award from the National Institute on Drug Abuse (NIDA), one of the most prestigious and competitive NIH research awards.

Artificial intelligence helps breast cancer patients avoid unnecessary chemotherapy

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune markers that could help doctors more accurately determine which breast cancer patients are unlikely to benefit from chemotherapy, potentially sparing some patients from unnecessary treatment.

Researchers identify control switch protein that starves tuberculosis bacteria

A protein that acts as a 'control switch,' preventing Mycobacterium tuberculosis from accessing the energy sources it needs to survive, has been identified by researchers at the University of Surrey.

Synthetic protein hybrid offers promising treatment for liver diseases

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold).

Cytoskeletal proteins in the cell nucleus influence brain development

The cytoskeleton gives cells their shape and helps them move. Researchers at Helmholtz Munich and the Ludwig Maximilian University now show that, in neural stem cells, proteins of the cytoskeleton are also found in the cell nucleus, where they can influence developmental programs.

New project aims to systematically map billion cellular interactions

Curtin University projects explore youth health issues in Western Australia

Curtin University Curtin University researchers will examine the 'partygoing' behaviours of young people in regional areas, the use of nicotine pouches and ways to promote physical activity among young people as part of new projects funded by Healthway.